Enhanced bioavailability and hepatoprotectivity of optimized ursolic acid–phospholipid complex

References

• Kashyap D, Tuli HS, Sharma AK. Ursolic acid (UA): a metabolite with promising therapeutic potential. Life Sci. 2016;146:201–213.
   PubMed Web of Science ®Google Scholar
• Yang L, Sun Z, Zu Y. Physicochemical properties and oral bioavailability of ursolic acid nanoparticles using supercritical anti-solvent (SAS) process. Food Chem. 2012;132:319–325.
   PubMed Web of Science ®Google Scholar
• Kazmi I, Afzal M, Rahman S, et al. Antiobesity potential of ursolic acid stearoyl glucoside by inhibiting pancreatic lipase. Eur J Pharmacol. 2013;709:28–36.
   PubMed Web of Science ®Google Scholar
• Ikeda Y, Murakami A, Ohigashi H. Ursolic acid: an anti- and pro-inflammatory triterpenoid. Mol Nutr Food Res. 2008;52:26–42.
   PubMed Web of Science ®Google Scholar
• Collins MA, Charles HP. Antimicrobial activity of carnosol and ursolic acid: two anti-oxidant constituents of Rosmarinusofficinalis L. Food Microbiol. 1987;4:311–315.
   Google Scholar
• Liu J. Oleanolic acid and ursolic acid: research perspectives. J Ethnopharmacol. 2005;100:92–94.
   PubMed Web of Science ®Google Scholar
• Martin-Aragón S, Heras DL, Sanchez-Reus MI, et al. Pharmacological modification of endogenous antioxidant enzymes by ursolic acid on tetrachloride-induced liver damage in rats and primary cultures of rat hepatocytes. Exp Toxicol Pathol. 2001;53:199–206.
   PubMed Web of Science ®Google Scholar
• Guti´errez-Rebolledo GA, Siordia-Reyes AG, et al. Hepatoprotective properties of oleanolic and ursolic acids in antitubercular drug-induced liver damage. Asian Pac J Trop Med. 2016;9:644–651.
   PubMed Web of Science ®Google Scholar
• Saravanan R, Viswanathan P, Pugalendi KV. Protective effect of ursolic acid on ethanol-mediated experimental liver damage in rats. Life Sci. 2006;78:713–718.
   PubMed Web of Science ®Google Scholar
• Liu J. Pharmacology of oleanolic acid and ursolic acid. J Ethnopharmacol. 1995;49:57–68.
   PubMed Web of Science ®Google Scholar
• Zhang H, Li X, Ding J, et al. Delivery of ursolic acid (UA) in polymeric nanoparticles effectively promotes the apoptosis of gastric cancer cells through enhanced inhibition of cyclooxygenase 2 (COX-2). Int J Pharm. 2013;441:261–268.
   PubMed Web of Science ®Google Scholar
• Jamal M, Imam SS, Aqil M, et al. Transdermal potential and anti-arthritic efficacy of Ursolic acid from niosomal gel systems. Int Immunopharmacol. 2015;29:361–369.
   PubMed Web of Science ®Google Scholar
• Wang M, Zhao T, Liu Y, et al. Ursolic acid liposomes with chitosan modification: promising antitumor drug delivery and efficacy. Mater Sci Eng C Mater Biol Appl. 2017;71:1231–1240.
   PubMed Web of Science ®Google Scholar
• Yang G, Yang T, Zhang W, et al. In vitro and in vivo antitumor effects of folate-targeted ursolic acid stealth liposome. J Agric Food Chem. 2014;62:2207–2215.
   PubMed Web of Science ®Google Scholar
• Mueller RH, Karsten M, Sven G. Solid lipid nanoparticles (SLN) for controlled drug delivery-a review of the state of the art. Eur J Pharm Biopharm. 2000;50:161–177.
   PubMed Web of Science ®Google Scholar
• Xie J, Li Y, Song L, et al. Design of a novel curcumin-soybean phosphatidylcholine complex-based targeted drug delivery systems. Drug Deliv. 2017;24:707–719.
   PubMed Web of Science ®Google Scholar
• Li J, Wang X, Zhang T, et al. A review on phospholipids and their main applications in drug delivery systems. Asian J Pharm Sci. 2015;10:81–98.
   Web of Science ®Google Scholar
• Fricker G, Kromp T, Wendel A, et al. Phospholipids and lipid-based formulations in oral drug delivery. Pharm Res. 2010;27:1469–1486.
   PubMed Web of Science ®Google Scholar
• Coimbra M, Isacchi B, van Bloois L, et al. Improving solubility and chemical stability of natural compounds for medicinal use by incorporation into liposomes. Int J Pharm. 2011;416:433–442.
   PubMed Web of Science ®Google Scholar
• Khan J, Alexander A, Ajazuddin, et al. Recent advances and future prospects of phyto-phospholipid complexationtechnique for improving pharmacokinetic profile of plant actives. J Control Release. 2013;168:50–60.
   PubMed Web of Science ®Google Scholar
• Lu MQ, Qiujun L, Xiang L, et al. Phyto-phospholipid complexes (phytosomes): a novel strategy to improve the bioavailability of active constituents. Asian J Pharm Sci. 2018.
   Google Scholar
• Bhattacharyya S, Ahmmed SM, Saha BP, et al. Soya phospholipid complex of mangiferin enhances its hepatoprotectivity by improving its bioavailability and pharmacokinetics. J Sci Food Agric. 2014;94:1380–1388.
   PubMed Web of Science ®Google Scholar
• Murugan V, Mukherjee K, Maiti K, et al. Enhanced Oral Bioavailability and Antioxidant Profile of Ellagic Acid by Phospholipids. J Agric Food Chem. 2009;57:4559–4565.
   PubMed Web of Science ®Google Scholar
• Maiti K, Mukherjee K, Gantait A, et al. Curcumin-phospholipid complex: preparation, therapeutic evaluation and pharmacokinetic study in rats. Int J Pharm. 2007;330:155–163.
   PubMed Web of Science ®Google Scholar
• Zhao X, Liu J, Hu Y, et al. Optimization on condition of glycyrrhetinic acid liposome by RSM and the research of its immunological activity. Int J Biol Macromol. 2012;51:299–304.
   PubMed Web of Science ®Google Scholar
• Vijesh AM, Isloor AM, Telkar S, et al. Molecular docking studies of some new imidazole derivatives for antimicrobial properties. Arab J Chem.
   Web of Science ®Google Scholar
• Zhou C, Chen K, Sun C, et al. Determination of oleanolic acid, ursolic acid and amygdalin in the flower of Eriobotrya japonica Lindl. by HPLC. Biomed Chromatogr. 2007;21:755–761.
   PubMed Web of Science ®Google Scholar
• ICH Harmonised Tripartite Guideline. Validation of analytical procedures: text and methodology Q2 (R1). 2005 Nov. p. 1–13.
   Google Scholar
• Yang X, Jiang Q, Du P, et al. Preparation and characterization of solidified oleanolic acid–phospholipid complex aiming to improve the dissolution of oleanolic acid. Asian J Pharm Sci. 2016;11:241–247.
   Web of Science ®Google Scholar
• Peng Q, Zhang Z, Sun X, et al. Mechanisms of phospholipid complex loaded nanoparticles enhancing the oral bioavailability. Mol Pharm. 2010;7:565–575.
   PubMed Web of Science ®Google Scholar
• Khan KA. The concept of dissolution efficiency. J Pharm Pharmacol. 1975;27:48–49.
   PubMed Web of Science ®Google Scholar
• Griffin S, Wyllie SG, Markham J. Determination of octanol-water partition coefficient for terpenoids using reversed-phase high-performance liquid chromatography. J Chromatogr A. 1999;864:221–228.
   PubMed Web of Science ®Google Scholar
• ICH Harmonised Tripartite Guideline. Stability testing of new drug substances and products. Q1A (R2). 2003 Feb. p. 1–18.
   Google Scholar
• Reitman S, Frankel S. A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. Am J Clin Pathol. 1957;28:56–63.
   PubMed Web of Science ®Google Scholar
• Kind PRN, King EJ. Estimation of plasma phosphatase by determination of hydrolysed phenol with amino-antipyrine. J Clin Pathol. 1954;7:322–326.
   PubMed Web of Science ®Google Scholar
• Malloy HT, Evelyn KA. The determination of bilirubin with the photoelectric colorimeter. J Biol Chem. 1937;119:481–490.
   Google Scholar
• Lowry O, Rosebrough NJ, Farr AL, et al. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265–275.
   PubMed Web of Science ®Google Scholar
• Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys. 1959;82:70–77.
   PubMed Web of Science ®Google Scholar
• Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med. 1967;70:158–169.
   PubMed Web of Science ®Google Scholar
• Habig WH, Pabst MJ, Jakoby WB. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem. 1974;249:7130–7139.
   PubMed Web of Science ®Google Scholar
• Dubler RE, Anderson BM. Simultaneous inactivation of the catalytic activities of yeast glutathione reductase by N-alkylmaleimides. Biochim Biophys Acta. 1981;659:70–85.
   PubMed Web of Science ®Google Scholar
• Kakkar B, Das PN, Viswanathan A. A modified spectrophotometric assay of superoxide dismutase. Indian J Biochem Biophys. 1984;21:130–132.
   PubMed Web of Science ®Google Scholar
• Beers RF, Seizer IW. A spectrophotometric method for measuring breakdown of hydrogen peroxide by catalase. J Biol Chem. 1952;115:130–140.
   Google Scholar
• Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxide for animal tissue by thiobarbituric acid reaction. Anal Biochem. 1979;95:351–358.
   PubMed Web of Science ®Google Scholar
• Bezerra MA, Santelli RE, Oliveira EP, et al. Response surface methodology (RSM) as a tool for optimization in analytical chemistry. Talanta. 2008;76:965–977.
   PubMed Web of Science ®Google Scholar
• Ferreira SL, Bruns RE, Ferreira HS, et al. Box-Behnken design: an alternative for the optimization of analytical methods. Anal Chim Acta. 2007;597:179–186.
   PubMed Web of Science ®Google Scholar
• Toyran N, Severcan F. Infrared spectroscopic studies on the dipalmitoylphosphatidylcholine bilayer interactions with calcium phosphate: effect of vitamin D2. Spectroscopy. 2002;16:399–408.
   Web of Science ®Google Scholar
• Pathan RA, Bhandari U. Gymnemic acid-phospholipid complex: preparation and characterization. J Dispersion Sci Technol. 2011;32:1165–1172.
   Web of Science ®Google Scholar
• Li J, Liu P, Liu JP, et al. Bioavailability and foam cells permeability enhancement of Salvianolic acid B pellets based on drug-phospholipids complex technique. Eur J Pharm Biopharm. 2013;83:76–86.
   PubMed Web of Science ®Google Scholar
• Yanyu X, Yunmei S, Zhipeng C, et al. The preparation of silybin-phospholipid complex and the study on its pharmacokinetics in rats. Int J Pharm. 2006;307:77–82.
   PubMed Web of Science ®Google Scholar
• Allam AN, Komeil IA, Fouda MA, et al. Preparation, characterization and in vivo evaluation of curcuminself-nano phospholipid dispersion as an approach to enhance oralbioavailability. Int J Pharm. 2015;489:117–123.
   PubMed Web of Science ®Google Scholar
• Cai X, Luan Y, Jiang Y, et al. Huperzine A-phospholipid complex-loaded biodegradable thermosensitive polymer gel for controlled drug release. Int J Pharm. 2012;433:102–111.
   PubMed Web of Science ®Google Scholar
• Gnananath K, Nataraj KS, Battu GR. Phospholipid complex technique for superior bioavailability of phytoconstituents. Adv Pharm Bull. 2017;7:35–42.
   PubMed Web of Science ®Google Scholar
• Yue PF, Yuan HL, Li XYYM, et al. Process optimization, characterization and evaluation in vivo of oxymatrine-phospholipid complex. Int J Pharm. 2010;387:139–146.
   PubMed Web of Science ®Google Scholar
• Anderson NH, Bauer M, Boussac N, et al. An evaluation of fit factors and dissolution efficiency for the comparison of in vitro dissolution profiles. J Pharm Biomed Anal. 1998;17:811–822.
   PubMed Web of Science ®Google Scholar